These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12657112)

  • 1. Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study.
    Bauknecht T; Hefti A; Morack G; Villena-Heinsen C; Wallwiener D; Elling D; Minckwitz GV; Mansouri K; Blatter J; Breitbach GP
    Int J Gynecol Cancer; 2003; 13(2):130-7. PubMed ID: 12657112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.
    Belpomme D; Krakowski I; Beauduin M; Petit T; Canon JL; Janssens J; Gauthier S; De Pauw A; Moreau V; Kayitalire L
    Gynecol Oncol; 2003 Oct; 91(1):32-8. PubMed ID: 14529659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer.
    Nogué M; Cirera L; Arcusa A; Batiste-Alentorn E; Balil A; Font A; Perez-Gracia JL; Carrasco EM; Tusquets I
    Anticancer Drugs; 2002 Sep; 13(8):839-45. PubMed ID: 12394269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer.
    Gupta SK; John S; Naik R; Arora R; Selvamani B; Fuloria J; Ganesh N; Awasthy BS
    Gynecol Oncol; 2005 Jul; 98(1):134-40. PubMed ID: 15894360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of gemcitabine plus cisplatin in previously untreated advanced ovarian cancer.
    Gallardo D; Calderillo G; Serrano A; Alexander F; Rodríguez G; Pérez L; de la Garza J; Orate-Ocaña L; Otero J
    Anticancer Res; 2006; 26(4B):3137-41. PubMed ID: 16886647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer.
    Friedlander M; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Varette C; Ripoche V; Kayitalire L
    Ann Oncol; 1998 Dec; 9(12):1343-5. PubMed ID: 9932166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer.
    Friedlander M; Buck M; Wyld D; Findlay M; Fitzharris B; De Souza P; Davies T; Kalimi G; Allan S; Perez D; Harnett P
    Int J Gynecol Cancer; 2007; 17(2):350-8. PubMed ID: 17362312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
    Laack E; Mende T; Dürk H; Kneba M; Dickgreber N; Welte T; Müller T; Scholtze J; Graeven U; Jasiewicz Y; Edler L; Hossfeld DK
    Eur J Cancer; 2002 Mar; 38(5):654-60. PubMed ID: 11916547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study.
    Tay SK; Ilanchadran A; Tan TY
    BJOG; 2006 Dec; 113(12):1388-92. PubMed ID: 17081186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trial.
    Zwitter M; Kovac V; Smrdel U; Vrankar M; Zadnik V
    J Thorac Oncol; 2009 Sep; 4(9):1148-55. PubMed ID: 19546818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.
    Nagourney RA; Brewer CA; Radecki S; Kidder WA; Sommers BL; Evans SS; Minor DR; DiSaia PJ
    Gynecol Oncol; 2003 Jan; 88(1):35-9. PubMed ID: 12504624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial.
    Sabbatini P; Aghajanian C; Leitao M; Venkatraman E; Anderson S; Dupont J; Dizon D; O'Flaherty C; Bloss J; Chi D; Spriggs D
    Clin Cancer Res; 2004 May; 10(9):2962-7. PubMed ID: 15131031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP; Hacking DJ; Goedhals L; Bezwoda WR
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8.
    Akcali Z; Calikusu Z; Sakalli H; Ozyilkan O
    Tumori; 2008; 94(4):474-80. PubMed ID: 18822681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer.
    Heinemann V; Wilke H; Mergenthaler HG; Clemens M; König H; Illiger HJ; Arning M; Schalhorn A; Possinger K; Fink U
    Ann Oncol; 2000 Nov; 11(11):1399-403. PubMed ID: 11142479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC).
    Antón A; Díaz-Fernández N; González Larriba JL; Vadell C; Masutti B; Montalar J; Barneto I; Artal A; Rosell R
    Lung Cancer; 1998 Nov; 22(2):139-48. PubMed ID: 10022221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
    Lutz MP; Van Cutsem E; Wagener T; Van Laethem JL; Vanhoefer U; Wils JA; Gamelin E; Koehne CH; Arnaud JP; Mitry E; Husseini F; Reichardt P; El-Serafi M; Etienne PL; Lingenfelser T; Praet M; Genicot B; Debois M; Nordlinger B; Ducreux MP;
    J Clin Oncol; 2005 Dec; 23(36):9250-6. PubMed ID: 16361622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.
    Sehouli J; Stengel D; Oskay G; Camara O; Hindenburg HJ; Klare P; Blohmer J; Heinrich G; Elling D; Ledwon P; Lichtenegger W;
    Ann Oncol; 2002 Nov; 13(11):1749-55. PubMed ID: 12419747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
    Walsh CS; Kamrava M; Rogatko A; Kim S; Li A; Cass I; Karlan B; Rimel BJ
    PLoS One; 2021; 16(6):e0252665. PubMed ID: 34081738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled efficacy analysis from a phase I-II study of biweekly irinotecan in combination with gemcitabine, 5-fluorouracil, leucovorin and cisplatin in patients with metastatic pancreatic cancer.
    Goel A; Grossbard ML; Malamud S; Homel P; Dietrich M; Rodriguez T; Mirzoyev T; Kozuch P
    Anticancer Drugs; 2007 Mar; 18(3):263-71. PubMed ID: 17264757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.